Gilead Sciences | GILD - EPS Earnings Per Share

Stock Price
149.40
Daily Change
3.17 2.17%
Monthly
23.10%
Yearly
52.39%
Q1 Forecast
137.58

Gilead Sciences reported $2.47 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.89 1.90 Feb/10 2026
FY2025Q3 Sep/2025 2.47 2.16 2.02 Oct/30 2025
FY2025Q2 Jun/2025 2.01 1.94 2.01 Aug/07 2025
FY2025Q1 Mar/2025 1.81 1.76 3.34 Apr/24 2025
FY2024Q4 Dec/2024 1.90 1.71 1.72 Feb/11 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
ALKERMES USD 0.49 0.03 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -0.51 1.62 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025